CIK 0001850119
- Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842040295
- Phone
- +1 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,212
- in 5 filings
Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-16 | Farid Adrienne Chief Operations Officer | Sale | −485 | $4.86 | $2K | 114,149 |
| 2024-02-16 | Farid Adrienne Chief Operations Officer | Exercise or conversion · Stock Option (right to buy) | −485 | 222,170 | ||
| 2024-02-06 | Carr Douglas SVP Finance & Operations | Sale | −557 | $4.49 | $2K | 303,580 |
| 2024-02-06 | Farid Adrienne Chief Operations Officer | Sale | −1,784 | $4.49 | $8K | 114,149 |
| 2024-02-05 | Carr Douglas SVP Finance & Operations | Sale | −643 | $3.84 | $2K | 304,137 |
| 2024-02-05 | Farid Adrienne Chief Operations Officer | Sale | −2,035 | $3.84 | $8K | 115,933 |
| 2023-12-04 | Pfeiffenberger Brent President and CEO | Grant or award | +1,173,775 | 1,173,775 | ||
| 2023-12-04 | Pfeiffenberger Brent President and CEO | Grant or award | +279,504 | 1,453,279 | ||
| 2023-12-04 | Pfeiffenberger Brent President and CEO | Grant or award · Stock Option (right to buy) | +573,691 | 573,691 | ||
| 2023-11-01 | Carr Douglas SVP Finance & Operations | Shares withheld for taxes | −16,611 | $1.49 | $25K | 304,780 |
| 2023-11-01 | Diem Michael Craig Chief Financial Officer | Shares withheld for taxes | −20,763 | $1.49 | $31K | 253,533 |
| 2023-06-27 | Carlo Rizzuto Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2023-06-27 | Riva Alessandro Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2023-06-27 | JIMENEZ JOSEPH Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2023-06-27 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2023-06-27 | Blackwell Kimberly Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2023-06-27 | Quimi Daphne Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2023-06-27 | Walbert Timothy P Director | Grant or award · Stock Option (right to buy) | +44,000 | 44,000 | ||
| 2023-05-15 | Carr Douglas SVP Finance & Operations | Grant or award | +120,846 | 321,391 | ||
| 2023-05-15 | Diem Michael Craig Chief Financial Officer | Grant or award | +151,058 | 274,296 |
Page 8 of 12 · 233 trades